3SBIO(01530)

28.300+0.160+0.57%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

- BREAKINGVIEWS-Biotech boom shows innovation is now made in China
  Reuters · 01-05 12:00
  BREAKINGVIEWS-Biotech boom shows innovation is now made in China
- Could The Market Be Wrong About 3SBio Inc. (HKG:1530) Given Its Attractive Financial Prospects?
  Simply Wall St. · 2025-12-31
  Could The Market Be Wrong About 3SBio Inc. (HKG:1530) Given Its Attractive Financial Prospects?
- GRAND PHARMA (00512): Self-Developed Global Innovative Radiopharmaceutical GPN01530 Approved for Clinical Trials in the U.S.
  Stock News · 2025-12-17
  GRAND PHARMA (00512): Self-Developed Global Innovative Radiopharmaceutical GPN01530 Approved for Clinical Trials in the U.S.
- Pfizer faces challenging years on fading COVID sales, margin pressure
  Reuters · 2025-12-16
  Pfizer faces challenging years on fading COVID sales, margin pressure
- Why 3SBio (SEHK:1530) Is Down 10.1% After HK$3.12 Billion Follow-on Equity Offering And Portfolio Shift
  Simply Wall St. · 2025-12-15
  Why 3SBio (SEHK:1530) Is Down 10.1% After HK$3.12 Billion Follow-on Equity Offering And Portfolio Shift
- 3SBio (SEHK:1530): Reassessing Valuation After Share Placement and Hair-Loss Business Spin-Off
  Simply Wall St. · 2025-12-14
  3SBio (SEHK:1530): Reassessing Valuation After Share Placement and Hair-Loss Business Spin-Off
- Hong Kong Stock Short Interest Data as of December 12
  Stock News · 2025-12-12
  Hong Kong Stock Short Interest Data as of December 12
- 3SBIO (01530) Issues 105 Million Shares Under Placement Agreement
  Stock News · 2025-12-09
  3SBIO (01530) Issues 105 Million Shares Under Placement Agreement
- 3SBio Raises HK$3.1 Billion Through Private Share Placement
  Reuters · 2025-12-09
  3SBio Raises HK$3.1 Billion Through Private Share Placement
- HK Stock Movement | 3SBIO (01530) Drops Nearly 5% After Raising Over HK$3 Billion in Placement, Plans Spin-off of Minde International
  Stock News · 2025-12-09
  HK Stock Movement | 3SBIO (01530) Drops Nearly 5% After Raising Over HK$3 Billion in Placement, Plans Spin-off of Minde International
- CMB International: 2025 Medical Insurance Catalog Continues Support for Innovation, Expects CXO Sector Recovery in H2
  Stock News · 2025-12-09
  CMB International: 2025 Medical Insurance Catalog Continues Support for Innovation, Expects CXO Sector Recovery in H2
- Assessing 3SBio (SEHK:1530)’s Valuation After a Recent Pullback in Share Price
  Simply Wall St. · 2025-12-06
  Assessing 3SBio (SEHK:1530)’s Valuation After a Recent Pullback in Share Price
- BOCOM INTL: China's 1st-8th Batch National Drug Procurement Renewal Rules Likely Moderate, Short-Term Catalysts Ample
  Stock News · 2025-12-05
  BOCOM INTL: China's 1st-8th Batch National Drug Procurement Renewal Rules Likely Moderate, Short-Term Catalysts Ample
- 10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled
  Stock News · 2025-12-03
  10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled
- Short Selling Statistics for Hong Kong Stocks | December 3
  Stock News · 2025-12-03
  Short Selling Statistics for Hong Kong Stocks | December 3
- BUZZ-HK-listed 3SBIO slips on discounted share sale
  Reuters · 2025-12-02
  BUZZ-HK-listed 3SBIO slips on discounted share sale
- 3SBio Seeks HK$3.12 Billion via Share Sale
  MT Newswires Live · 2025-12-02
  3SBio Seeks HK$3.12 Billion via Share Sale
- BRIEF-3SBio To Place 105.2 Million Shares
  Reuters · 2025-12-02
  BRIEF-3SBio To Place 105.2 Million Shares
- 3SBIO (01530) Plans 6.50% Discounted Share Placement to Raise Approximately HK$3.087 Billion
  Stock News · 2025-12-02
  3SBIO (01530) Plans 6.50% Discounted Share Placement to Raise Approximately HK$3.087 Billion
- 3SBio - to Place 105.2 Mln Shares at HK$29.62 per Placing Share
  THOMSON REUTERS · 2025-12-02
  3SBio - to Place 105.2 Mln Shares at HK$29.62 per Placing Share
Company Profile
Company Name
3SBIO
Market
SEHK
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://www.3sbio.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
3SBio Inc is an investment holding company principally engaged in the development, production, marketing and sale of biopharmaceutical products. The Company's main products include biopharmaceuticals such as TPIAO, EPIAO, Yisaipu, and Cipterbin, as well as small moleculessuch as Mandi and Remitch. The Company is also engaged in the contract development and manufacturing operations (CDMO) business that provides customers with research, development and production of a variety of biopharmaceuticals and therapeutic technology platform services. The Company's products are mainly used for chemotherapy-induced thrombocytopenia (CIT), anemia caused by chronic kidney disease (CKD), treatment of chemotherapy-induced anemia (CIA), ankylosing spondylitis (AS) and psoriasis. The Company mainly operates its businesses in the domestic and overseas markets.

1D
5D
Day
Week
Month

Loading ...

High

28.980

Open

28.140

Volume%

1.73

Low

27.880

28.140

T/O Rate

0.58%

To The Moon

3SBIO(01530)

Company Profile

Most Discussed